The case for heat-treated blood products

Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes.

Haemophilia : the official journal of the World Federation of Hemophilia·2018

Genotypes, phenotypes and whole genome sequence: Approaches from the My Life Our Future haemophilia project.

Haemophilia : the official journal of the World Federation of Hemophilia·2018

Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project.

Haemophilia : the official journal of the World Federation of Hemophilia·2018

First-year results of an expanded humanitarian aid programme for haemophilia in resource-constrained countries.

Haemophilia : the official journal of the World Federation of Hemophilia·2018

Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A-LONG study subjects with severe haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia·2017

Changes in health-related quality of life with treatment of longer-acting clotting factors: results in the A-LONG and B-LONG clinical studies.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Comparison of radial artery and saphenous vein as the third conduit with bilateral internal mammary arteries in coronary bypass surgery.

JTCVS open·2026

Hemiarch repair versus total-arch repair with frozen elephant trunk for acute type A aortic dissection: A propensity score-matched study.

JTCVS open·2026

Is systemic anticoagulation necessary during intraoperative venoarterial extracorporeal membrane oxygenation for bilateral lung transplantation? A feasibility study comparing zero-, low-, and high-intensity heparin strategies.

JTCVS open·2026

HEPARIN-INDUCED THROMBOCYTOPENIA AND ITS IMPACT ON INPATIENT OUTCOMES IN INFLAMMATORY BOWEL DISEASE.

The American journal of the medical sciences·2026

PCBP1 joins the regulatory network of the endothelial-to-hematopoietic transition.

Experimental hematology·2026

Berotralstat Tolerability and Effectiveness in Hereditary Angioedema: Berolife Study Results.

Clinical and translational allergy·2026

Related Experiment Videos

The case for heat-treated blood products

Related Concept Videos

Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes.

Genotypes, phenotypes and whole genome sequence: Approaches from the My Life Our Future haemophilia project.

Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project.

First-year results of an expanded humanitarian aid programme for haemophilia in resource-constrained countries.

Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A-LONG study subjects with severe haemophilia A.

Changes in health-related quality of life with treatment of longer-acting clotting factors: results in the A-LONG and B-LONG clinical studies.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Comparison of radial artery and saphenous vein as the third conduit with bilateral internal mammary arteries in coronary bypass surgery.

Hemiarch repair versus total-arch repair with frozen elephant trunk for acute type A aortic dissection: A propensity score-matched study.

Is systemic anticoagulation necessary during intraoperative venoarterial extracorporeal membrane oxygenation for bilateral lung transplantation? A feasibility study comparing zero-, low-, and high-intensity heparin strategies.

HEPARIN-INDUCED THROMBOCYTOPENIA AND ITS IMPACT ON INPATIENT OUTCOMES IN INFLAMMATORY BOWEL DISEASE.

PCBP1 joins the regulatory network of the endothelial-to-hematopoietic transition.

Berotralstat Tolerability and Effectiveness in Hereditary Angioedema: Berolife Study Results.

Related Experiment Videos

The case for heat-treated blood products

Related Concept Videos

Related Articles